Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis

Our analysis revealed that oxaliplatin-based chemotherapy offers a significant survival benefit in stage III CC patients with T3 tumors. In contrast, no survival benefit was observed for T1-2 or T4 patients. These results suggested that T stage plays a more crucial role than N stage in predicting treatment benefit, highlighting the need for tailored treatment strategies based on tumor characteristics.

Authors

Institutions

Publication Details

Journal
ESMO Open
Published
2025-03-01
DOI
https://doi.org/10.1016/j.esmoop.2025.104481
Citations
1
Primary Topic
Colorectal Cancer Surgical Treatments
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis

Rachel Kerr, Daniel G. Haller, Benoist Chibaudel, Thomas J. George et al.
1 citations
ESMO Open
Colorectal Cancer Surgical Treatments
1.05
article

Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis

Rachel Kerr, Daniel G. Haller, Benoist Chibaudel, Thomas J. George, T. Yoshino, Qian Shi, Romain Cohen, Sara Lonardi, Aimery de Gramont, Norman Wolmark, Greg Yothers, Jean‐Baptiste Bachet, Morteza Raeisi, Einat Shacham‐Shmueli, Thierry André, Richard M. Goldberg, Hans‐Joachim Schmoll
article en
1 citations

Abstract

Our analysis revealed that oxaliplatin-based chemotherapy offers a significant survival benefit in stage III CC patients with T3 tumors. In contrast, no survival benefit was observed for T1-2 or T4 patients. These results suggested that T stage plays a more crucial role than N stage in predicting treatment benefit, highlighting the need for tailored treatment strategies based on tumor characteristics.

ESMO OpenVol. 10(3)
Twitter (United States) (US), West Virginia University (US), Inserm (FR), Tel Aviv University (IL), Sheba Medical Center (IL), West Virginia University Hospitals (US), Sorbonne Université (FR), University of Oxford (GB), La Ligue Contre le Cancer (FR), Fondation FondaMental (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Saint-Antoine (FR), Istituto Oncologico Veneto (IT), Pitié-Salpêtrière Hospital (FR), Centre de Recherche Saint-Antoine (FR), Institut Hospitalier Franco Britannique (FR), National Cancer Center Hospital East (JP), Mayo Clinic in Florida (US), NSABP Foundation (US), Martin Luther University Halle-Wittenberg (DE), University of Pennsylvania (US)
Good health and well-being
Openalex Percentile: Top 25%
Colorectal Cancer Surgical Treatments
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.